Chenyuan Liu, Yi Lu, Wanyu Yang (2026). Excessive Pharmaceutical Marketing Expenditure: Policy Remedies from China. The Review of Economics and Statistics.DOI
Lan Zou, Chenyuan Liu (2026). Little Learning, Large Inertia: Deductible Choice in Swiss Health Insurance. Social Science Research Network.DOI
Hong-Lin Li, Chenyuan Liu, Justin R. Sydnor (2025). Community Rating and Vertical Price Distortions in Insurance Menus. Social Science Research Network.DOI
Chenyuan Liu, Yueyuan Ma, Binzhen Wu (2023). Information Disclosure and Marriage Quality: Evidence from Premarital Medical Exams. Social Science Research Network.DOI
Chenyuan Liu, Justin Sydnor (2022). Dominated Options in Health Insurance Plans. American Economic Journal-Economic Policy, Vol. 14, No. 1.DOI
Yu Ding, Chenyuan Liu (2021). Alternative payment models and physician treatment decisions: Evidence from lower back pain. Journal Of Health Economics, Vol. 800.DOI
Chenyuan Liu (2019). Sorting on Plan Designs: Theory and Evidence from the ACA.
Chenyuan Liu, Justin R. Sydnor (2017). How Common are Dominated Health Plan Options? Evidence from Employer Health Benefits with High-Deductible Plans.DOI
邢科,刘晨源(2014). 浅谈通货膨胀目标制的有效性. 《金融理论与实践》.
预印本
Honglin Li, Chenyuan Liu, Justin Sydnor (2026). Is Choice Overload a Problem for Health-Plan Choice? Evidence from the ACA Marketplace. SSRN Electronic Journal.DOI
Chenyuan Liu, Jiacheng Liu, Li Wei, Yi Yao (2026). The Downside of More: Choice Overload in Health Insurance Markets. SSRN Electronic Journal.DOI
Chenyuan Liu, Yi Lu, Ronghe Sun, Wanyu Yang (2026). Expected Insurance Coverage and Pharmaceutical Innovation: Evidence from China's National Drug Price Negotiation Policy. SSRN Electronic Journal.DOI
Chenyuan Liu, Haiting Tian, Wanyu Yang (2026). Decentralized Policy-making and Market Distortions: Evidence from China's Drug Formulary Design. SSRN Electronic Journal.DOI